Abstract
Gut-microbiota (GM) is considered a hidden metabolic organ of the human body, providing biochemical pathways which are absent in the host. Balanced diet with calorie restriction (CR) promotes growth of healthy microbiota, leading to longevity by down-regulating inflammatory responses. While, dysbiosis leads to body dysfunction, inducing metabolic disorders, causing poor epithelial architecture, and impeding the development of mucosal-associated lymphoid tissue, resulting in with reduced T and B cell populations, rendering the body prone to infections, cancer and allergy. The GM enzymes activity is a new risk factor for cancer while gut-derived interleukin-6 is associated with hepatocellular carcinoma development. GM can also influence the brain biochemistry and emotional behavior. The altered GM affects the genes involved in second messenger pathway and long-term potentiation, leading to their differential expression in the hippocampus, cortex, striatum and cerebellum. In addition, the dysbiotic GM is associated with autistic disorder. Living with dysbiotic GM is possible with consequences of serious impairments.
Keywords: Allergy, cancer, gut-microbiota, metabolism, immunity, heart diseases, nervous system.
CNS & Neurological Disorders - Drug Targets
Title:Implication of Gut Microbiota in Human Health
Volume: 13 Issue: 8
Author(s): Imran Khan, Muhammad Yasir, Esam I. Azhar, Taha Kumosani, Elie K. Barbour, Fehmida Bibi and Mohammad A. Kamal
Affiliation:
Keywords: Allergy, cancer, gut-microbiota, metabolism, immunity, heart diseases, nervous system.
Abstract: Gut-microbiota (GM) is considered a hidden metabolic organ of the human body, providing biochemical pathways which are absent in the host. Balanced diet with calorie restriction (CR) promotes growth of healthy microbiota, leading to longevity by down-regulating inflammatory responses. While, dysbiosis leads to body dysfunction, inducing metabolic disorders, causing poor epithelial architecture, and impeding the development of mucosal-associated lymphoid tissue, resulting in with reduced T and B cell populations, rendering the body prone to infections, cancer and allergy. The GM enzymes activity is a new risk factor for cancer while gut-derived interleukin-6 is associated with hepatocellular carcinoma development. GM can also influence the brain biochemistry and emotional behavior. The altered GM affects the genes involved in second messenger pathway and long-term potentiation, leading to their differential expression in the hippocampus, cortex, striatum and cerebellum. In addition, the dysbiotic GM is associated with autistic disorder. Living with dysbiotic GM is possible with consequences of serious impairments.
Export Options
About this article
Cite this article as:
Khan Imran, Yasir Muhammad, Azhar I. Esam, Kumosani Taha, Barbour K. Elie, Bibi Fehmida and Kamal A. Mohammad, Implication of Gut Microbiota in Human Health, CNS & Neurological Disorders - Drug Targets 2014; 13 (8) . https://dx.doi.org/10.2174/1871527313666141023153506
DOI https://dx.doi.org/10.2174/1871527313666141023153506 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coenzyme Q10 and Neurological Diseases: An Update
Letters in Drug Design & Discovery Recent Advancements in Pharmacological Stent Therapy Using Polymeric Materials: Opportunities and Challenges
Current Drug Delivery Q Fever Endocarditis
Infectious Disorders - Drug Targets A SELDI-TOF-MS Study in Lacunar Stroke with Subsequent Haptoglobin Phenotyping
Current Neurovascular Research Novel Pyrazolo[4, 3-c]Quinolin-3-One Derivatives as PDE5A Inhibitors
Current Topics in Medicinal Chemistry microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design Non Peptidic Urotensin II Antagonists: Perspectives for a New Class of Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Innovative Formulations for the Controlled and Site-specific Delivery of Antiinflammatory Drugs
Current Pharmaceutical Design Glucans as Biological Response Modifiers
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review of Feature Extraction from ECG Signals and Classification/ Detection for Ventricular Arrhythmias
Recent Advances in Computer Science and Communications Omega-3 Fatty Acids for Nutrition and Medicine: Considering Microalgae Oil as a Vegetarian Source of EPA and DHA
Current Diabetes Reviews Rationale of Statin Therapy in Septic Patients
Current Vascular Pharmacology Dietary Antioxidants as Potential Pharmacological Agents for Ischemic Stroke
Current Medicinal Chemistry Update on the Evidence of Statin Treatment to Reduce Plaque Vulnerability
Drug Metabolism Letters Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics
Current Respiratory Medicine Reviews Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry Immunologic Modulations to Enhance Post-Stroke Recovery
Current Immunology Reviews (Discontinued) All for Statins and Statins for All; An Update
Current Pharmaceutical Design Cardiovascular Risk in Patients with Primary Hyperparathyroidism
Current Pharmaceutical Design Considering Circadian Pattern of Blood Pressure in the Treatment of Hypertension via Chronotherapy: A Conducive or Maladroit Approach
Current Drug Targets